A lack of tumor-induced suppression of normal GH secretion and the effects of local factors such as ischemia, fibrosis, cytokines, and inflammation could all play a role in this interesting phenomenon and justify a “sooner the better” approach to postoperative GH scheduling. This evidence concerns the gene GH1 and neoplasm.